GlassScriptPhysician profile
Batya Reena Goldwaser
NPI 1326277047
$884.53
in general payments reported to CMS, 2019-2025
7 companies · $28.86 in 2025
The $28.86 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.29 · 2020: $14.92 · 2021: $314 · 2022: $268 · 2023: $158 · 2024: $84.74 · 2025: $28.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258 · Education: $13.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $257.94 |
| Education | $13.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $425.51 | 2020-2023 | |
| Zimvie INC. | $191.98 | 2022-2023 | |
| Keystone Dental INC. | $124.30 | 2022 | |
| Stryker Corporation | $84.74 | 2024 | Na |
| Nusmile, LTD. | $28.86 | 2025 | Ab - Zarc System |
| Pacira Pharmaceuticals Incorporated | $15.29 | 2019 | |
| Gc America INC. | $13.85 | 2023 | Mipaste One |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Batya Goldwaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.